MINNEAPOLIS, May 19, 2020 /PRNewswire/ — VigiLanz, a clinical surveillance company, today announced findings from a new survey of 100 hospital and health system leaders on hospital safety challenges and improvements. With unintended harm occurring in one-third of hospital admissions,i and medical errors being the third leading cause of death after heart disease and cancer,ii the survey aimed to take stock of current hospital safety practices.
Conducted in February 2020 by Sage Growth Partners, a healthcare consultancy, the independent survey asked c-suite executives, physicians, nurses, infection preventionists, pharmacists, and more about their top patient safety challenges, where the most safety improvements are occurring, if technology is enhancing patient safety, and which patient-safety improvement approaches are most successful.
The full results were published in VigiLanz’s Hospital Safety Report 2020.
Key findings include:
Nearly one quarter of respondents are unhappy with their organization’s safety performance; more than a quarter say they are less confident about hospital safety than the typical consumer
Medication errors top hospitals’ safety challenges, but 40% of respondents say error rates are decreasing
Hospitals are aware of the benefits of safety-enhancing technology, but 29% don’t use it
One in five hospitals may not be able to respond to a viral outbreak quickly
“As the U.S. fights the COVID-19 pandemic, hospitals face new and unprecedented challenges to keep patients safe,” said VigiLanz Chairman and CEO David Goldsteen, MD. “We are already seeing increasing adoption of technology solutions to help manage medication scarcity and use, infection control challenges, and much more, specifically pertaining to COVID-19. Hospitals are recognizing that use of technology and real-time intelligence directly correlate with patient safety and outcomes. While technology is not the only lever hospitals should be using to improve safety, it is an essential and foundational element of success.”
Methodology
VigiLanz commissioned Sage Growth Partners, a healthcare consultancy, to conduct the independent survey of 100 hospital and health system leaders in February 2020. Respondent titles included chief executive officer (16%), chief medical officer (5%), chief nursing officer (11%), quality executive (8%), pharmacy executive (34%), infection prevention executive (23%), and other (3%). For more demographics and methodology, download the full report here.
About VigiLanz
Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.
i “Global Trigger Tool Shows That Adverse Events In Hospitals May Be Ten Times Greater Than Previously Measured,” Health Affairs: https://www.healthaffairs.org/doi/10.1377/hlthaff.2011.0190.
ii “Medical error—the third leading cause of death in the US,” BMJ 2016;353:i213: https://www.bmj.com/content/353/bmj.i2139.
Media Contact
Vanessa Ulrich
(410) 534.1161
vulrich@sage-growth.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/vigilanz-releases-new-survey-findings-on-hospital-safety-301061684.html
SOURCE VigiLanz
MEMPHIS, Tenn., July 5, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare announced its four Memphis-based adult hospitals…
TEMPE, Ariz., July 5, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in June…
mCare Digital unveils the mCareWatch MW-241 powered by KORE connectivity ATLANTA, July 5, 2024 /PRNewswire/…
Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of…
Image acquisition and defocusing correction techniques enable observations of atomic-scale magnetic fields at never-before-seen resolution…
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical…